Hypertension in hemodialysis patients: An opinion-based update

Seminars in Dialysis

Volumn 27, Issue 2, 2014, Pages 146-153

  Shafi, Tariq ^a,b   Waheed, Sana ^a   Zager, Philip G ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; COMPLICATION; HUMAN; HYPERTENSION; KIDNEY FAILURE, CHRONIC; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 84895139796     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12195     Document Type: Article

References (80)

1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG: Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115(4):291-297, 2003
2. Annual Report of the Dialysis Outcomes and Practice Patterns Study: Hemodialysis Data 1999-2008. Arbor Research Collaborative for Health, Ann Arbor, MI. Accessed on 8/24/2013 at http://www.dopps.org/annualreport/.
3. Henderson LW: Symptomatic intradialytic hypotension and mortality: an opinionated review. Semin Dial 25(3):320-325, 2012
4. Giles TD, Berk BC, Black HR, Cohn JN, Kostis JB, Izzo JL, Jr, Weber MA: Expanding the definition and classification of hypertension. J Clin Hypertens (Greenwich) 7(9):505-512, 2005
5. Czarkowski M, Staszkow M, Kostyra K, Shebani Z, Niemczyk S, Matuszkiewicz-Rowinska J: Determining the accuracy of blood pressure measurement by the Omron HEM-907 before and after hemodialysis. Blood Press Monit 14(5):232-238, 2009
6. Roberts MA, Pilmore HL, Tonkin AM, Garg AX, Pascoe EM, Badve SV, Cass A, Ierino FL, Hawley CM: Beta-Blocker to Lower zCardiovascular Dialysis Events (BLOCADE) Feasibility Study Trial Management Committee: challenges in blood pressure measurement in patients treated with maintenance hemodialysis. Am J Kidney Dis 60(3):463-472, 2012
7. K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45(4 Suppl 3):S1-153, 2005
8. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D: American Heart Association, American Society of Hypertension, Preventive Cardiovascular Nurses Association: Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 52(1):1-9, 2008
9. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering TG, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G: ESH Working Group on Blood Pressure Monitoring: European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 24(12):779-785, 2010
10. Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C: Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 47(1):62-68, 2006
11. Moriya H, Oka M, Maesato K, Mano T, Ikee R, Ohtake T, Kobayashi S: Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol 3(2):416-422, 2008
12. Thompson AM, Pickering TG: The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney Int 70(6):1000-1007, 2006
13. Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London GM: Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int 77(4):273-284, 2010
14. Agarwal R: Managing hypertension using home blood pressure monitoring among haemodialysis patients-a call to action. Nephrol Dial Transplant 25(6):1766-1771, 2010
15. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 334(1):13-18, 1996
16. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D: Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 358(9294):1682-1686, 2001
17. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288(23):2981-2997, 2002
18. Wright JT, Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG, African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288(19):2421-2431, 2002
19. Anonymous: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 265(24):3255-3264, 1991
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289(19):2560-2572, 2003
21. Authors/Task Force Members, Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, ESH Scientific Council, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, ESC Committee for Practice Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document Reviewers, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Ryden L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA: 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159-2219, 2013
22. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, Lefevre ML, Mackenzie TD, Ogedegbe O, Smith SC, Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT, Jr, Narva AS, Ortiz E: 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 2013 Dec 18. doi: 10.1001/jama.2013.284427. [Epub ahead of print]
23. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD: Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension 45(4):811-817, 2005
24. Robinson BM, Tong L, Zhang J, Wolfe RA, Goodkin DA, Greenwood RN, Kerr PG, Morgenstern H, Li Y, Pisoni RL, Saran R, Tentori F, Akizawa T, Fukuhara S, Port FK: Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 82(5):570-580, 2012
25. Lacson E, Jr, Lazarus JM: The association between blood pressure and mortality in ESRD-not different from the general population? Semin Dial 20(6):510-517, 2007
26. Agarwal R: The controversies of diagnosing and treating hypertension among hemodialysis patients. Semin Dial 25(4):370-376, 2012
27. Mehrotra R, Agarwal R, Townsend R, Goldfarb S: End-Stage Renal Disease and Dialysis: NephSAP, 2012
28. Weir MR: Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? Con position J Am Soc Hypertens 6(6):443-447, 2012
29. Brenner H: Bias due to non-differential misclassification of polytomous confounders. J Clin Epidemiol 46(1):57-63, 1993
30. Longenecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR: Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 11(3):520-529, 2000
31. Gul A, Miskulin D, Gassman J, Harford A, Horowitz B, Chen J, Paine S, Bedrick E, Kusek JW, Unruh M, Zager P, for the BID Pilot Study Investigators: Design of the Blood Pressure in Dialysis Pilot Study. Am J Med Sci 2013 Jan 31. [Epub ahead of print]
32. Taler SJ, Agarwal R, Bakris GL, Flynn JT, Nilsson PM, Rahman M, Sanders PW, Textor SC, Weir MR, Townsend RR: KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD. Am J Kidney Dis 62(2):201-213, 2013
33. KDIGO: KDIGO Blood Pressure Work Group: KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 2(Suppl):337-414, 2012
34. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363(24):2287-2300, 2010
35. Agarwal R, Alborzi P, Satyan S, Light RP: Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 53(3):500-507, 2009
36. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R: Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 4(6):1089-1096, 2009
37. Dharia SM, Brown LK, Unruh ML: Recognition and treatment of obstructive sleep apnea. Semin Dial 26(3):273-277, 2013
38. Bazzano LA, Khan Z, Reynolds K, He J: Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50(2):417-423, 2007
39. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233-1241, 2003
40. Matsuda K, Shimamoto K, Ura N, Ogata H, Shizukuda Y, Iwakura M, Nozawa A, Kikuchi K, Iimura O: A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment. Endocrinol Jpn 36(5):681-686, 1989
41. Mise K, Ubara Y, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Hoshino J, Sawa N, Hashimoto M, Fujii T, Sasano H, Takaichi K: Cushing's syndrome after hemodialysis for 21 years. J Clin Endocrinol Metab 98(1):13-19, 2013
42. Rossignol P, Kessler M, Zannad F: Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens 22(1):59-64, 2013
43. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR: Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375(9718):895-905, 2010
44. Shafi T, Sozio S, Bandeen-Roche K, Ephraim P, Luly J, McDermott A, Scialla J, Crews D, Tangri N, Miskulin D, Michels W, St. Peter W, Wu A, Jaar B, Zager P, Boulware L: Predialysis Systolic Blood Pressure Variability and Outcomes in Incident Hemodialysis Patients: The DEcIDE Network Patient Outcomes in ESRD Study. J Am Soc Nephrol 2014 Jan 2. [Epub ahead of print]
45. Chang TI, Flythe JE, Brunelli SM, Muntner P, Greene T, Cheung AK, Chertow GM: Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. J Hum Hypertens 28(1):18-24, 2014
46. Rossignol P, Cridlig J, Lehert P, Kessler M, Zannad F: Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL. Hypertension 60(2):339-346, 2012
47. Flythe JE, Kunaparaju S, Dinesh K, Cape K, Feldman HI, Brunelli SM: Factors associated with intradialytic systolic blood pressure variability. Am J Kidney Dis 59(3):409-418, 2012
48. Flythe JE, Inrig JK, Shafi T, Chang TI, Cape K, Dinesh K, Kunaparaju S, Brunelli SM: Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis 61(6):966-974, 2013
49. Inrig JK, Oddone EZ, Hasselblad V, Gillespie B, Patel UD, Reddan D, Toto R, Himmelfarb J, Winchester JF, Stivelman J, Lindsay RM, Szczech LA: Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 71(5):454-461, 2007
50. Van Buren PN, Kim C, Toto RD, Inrig JK: The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up. Int J Artif Organs 35(12):1031-1038, 2012
51. Rubinger D, Backenroth R, Sapoznikov D: Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS ONE 7(5):e36943, 2012
52. Inrig JK, Van Buren P, Kim C, Vongpatanasin W, Povsic TJ, Toto R: Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction. Clin J Am Soc Nephrol 7(8):1300-1309, 2012
53. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ: Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research: Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45(1):142-161, 2005
54. Kidney Disease Outcomes Quality Initiative (K/DOQI): K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43(5 Suppl 1):S1-290, 2004
55. da Silva GV, de Barros S, Abensur H, Ortega KC, Mion D, Jr: Cochrane Renal Group Prospective Trial Register: CRG060800146: Home blood pressure monitoring in blood pressure control among haemodialysis patients: an open randomized clinical trial. Nephrol Dial Transplant 24(12):3805-3811, 2009
56. Adeseun GA, Bonney CC, Rosas SE: Health literacy associated with blood pressure but not other cardiovascular disease risk factors among dialysis patients. Am J Hypertens 25(3):348-353, 2012
57. Mason J, Khunti K, Stone M, Farooqi A, Carr S: Educational interventions in kidney disease care: a systematic review of randomized trials. Am J Kidney Dis 51(6):933-951, 2008
58. Kauric-Klein Z: Blood pressure knowledge in hypertensive hemodialysis patients. CANNT J 22(4):18-25, 2012
59. Moattari M, Ebrahimi M, Sharifi N, Rouzbeh J: The effect of empowerment on the self-efficacy, quality of life and clinical and laboratory indicators of patients treated with hemodialysis: a randomized controlled trial. Health Qual Life Outcomes 10: 115, 2012
60. Tsai YC, Tsai JC, Chen SC, Chiu YW, Hwang SJ, Hung CC, Chen TH, Kuo MC, Chen HC: Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Am J Kidney Dis 63(1):68-75, 2014
61. Agarwal R, Weir MR: Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 5(7):1255-1260, 2010
62. Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E: Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis 61(6):957-965, 2013
63. Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Moissl U, Kotanko P, Levin NW, Säemann MD, Kalantar-Zadeh K, Port FK, Wabel P: Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol 38(1):78-90, 2013, doi: 10.1159/000353104
64. Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, Toto RD, Stivelman J, Winchester JF, Zillman LA, Califf RM, Owen WF, Jr: Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol 16(7):2162-9, 2005
65. Mc Causland FR, Waikar SS, Brunelli SM: Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int 82(2):204-211, 2012
66. Munoz Mendoza J, Sun S, Chertow GM, Moran J, Doss S, Schiller B: Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrol Dial Transplant 26(4):1281-1287, 2011
67. Thein H, Haloob I, Marshall MR: Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain. Nephrol Dial Transplant 22(9):2630-2639, 2007
68. Gumrukcuoglu HA, Ari E, Akyol A, Akdag S, Simsek H, Sahin M, Gunes Y, Tuncer M: Effects of lowering dialysate sodium on carotid artery atherosclerosis and endothelial dysfunction in maintenance hemodialysis patients. Int Urol Nephrol 44(6):1833-1839, 2012
69. Elshahawy Y, Sany D, Shawky S: Outcome of individualized dialysate sodium concentration for hemodialysis patients. Saudi J Kidney Dis Transpl 24(3):507-513, 2013
70. Dunlop JL, Vandal AC, de Zoysa JR, Gabriel RS, Haloob IA, Hood CJ, Matheson PJ, McGregor DO, Rabindranath KS, Semple DJ, Marshall MR: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol 14:149, 2013
71. Sozio S, Shafi T, St. Peter W, Bandeen-Roche K, Ephraim P, Luly J, Boulware L: Antihypertensive Medications and Mortality in Incident Hemodialysis Patients: A Marginal Structural Analysis of a National Cohort (abstract). American Society of Nephrology Kidney Week 2013. J Am Soc Nephrol 24:448A, 2013
72. Shafi T, St. Peter W, Sozio S, Ephraim P, Bandeen-Roche K, Boulware L: Renin-Angiotensin System (RAS) Blocking Drugs Reduce the Risk of Death in US Incident Hemodialysis (HD) Patients (abstract). American Society of Nephrology Kidney Week 2013. J Am Soc Nephrol 24:451A, 2013
73. Converse RL, Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327(27):1912-1918, 1992
74. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH: Sympathetic nerve activity in end-stage renal disease. Circulation 106(15):1974-1979, 2002
75. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS: Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105(11):1354-1359, 2002
76. Zazgornik J, Biesenbach G, Janko O, Gross C, Mair R, Brucke P, Debska-Slizien A, Rutkowski B: Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients. Am J Hypertens 11(11 Pt 1):1364-1370, 1998
77. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M: Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903-1909, 2010
78. Esler MD, Krum H, Schlaich M, Schmieder RE, Bohm M, Sobotka PA: Symplicity HTN-2 Investigators: Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 126(25):2976-2982, 2012
79. Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Bohm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD: Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol 168(3):2214-2220, 2013
80. Thompson S, Hemmelgarn B, Wiebe N, Majumdar S, Klarenbach S, Jindal K, Manns B, Mortis G, Campbell P, Tonelli M: Alberta Kidney Disease Network: Clinical decision support to improve blood pressure control in hemodialysis patients: a nonrandomized controlled trial. J Nephrol 25(6):944-953, 2012